Soumya Surath Panda

7PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Studies of Asian societyUrban community development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 27, 2026
Primary Platinum-Resistant Ovarian Cancer: Clinicopathologic Correlates and Outcomes From a Multicenter Prospective Indian Registry.

|Feb 07, 2026
Real-world data of PARP inhibitors in first-line maintenance for BRCA-mutated or HRD-positive advanced ovarian cancer: a multicentre retrospective study from India.

Susheel Kumar Yeshala, Soumya Surath Panda, Lalatendu Moharana

|Dec 31, 2025
Clinical and Survival Insights into Carcinoma Penis: A Retrospective Analysis at a Tertiary Care Facility.

Santosh Kumar Swain, Lalatendu Moharana, Ghanashyam Biswas

|Dec 22, 2025
Consensus Statements for Clinical Practice in Advanced/Metastatic Colorectal Cancers in India Using a Modified Delphi Method.

Anant Ramaswamy, Sujay Srinivas, Viraj Lavingia

|Mar 24, 2025
A Multicenter Study on the Challenges and Real-World Utilization of Immune Checkpoint Inhibitors in Resource-Constrained Settings: Insights and Implications from India.

Ashwin Oommen Philips, Sunu Cyriac, P Unnikrishnan

|Jun 26, 2024
Adolescent and Young Adults with Gastric Cancer (AYA-GC)-The Dilemma of an Under-Represented Group: A Multi-Institutional Analysis from the Indian Subcontinent.

Soumya Surath Panda, Swati Sucharita Mohanty, Antara Sanyal

Pageof 2

Frequent Collaborators

6 joint publications

Laltendu Moharana

5 joint publications

Amit Sehrawat

4 joint publications

Saju Sv

4 joint publications

Swati Sucharita Mohanty